Document Detail


Regional fat loss from the thigh in obese women after adrenergic modulation.
MedLine Citation:
PMID:  2894247     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Beta-adrenergic stimulation and alpha 2-adrenergic inhibition increase lipolysis from fat cells. Twenty-eight obese women were placed on a calorie-restricted diet and one of five treatments was applied to one thigh three to five times per week for four weeks: (1) isoproterenol injections; (2) cream containing colforsin (forskolin), aminophylline, and yohimbine; (3) yohimbine cream; (4) colforsin cream; or (5) aminophylline cream. The opposite thigh was treated with a placebo (injection or cream). The treated thighs lost significantly more girth after treatment, both by injection and by cream. No adverse reactions were attributable to either the cream or the injections. It is concluded that local fat reduction from the thigh can be safely accomplished.
Authors:
F L Greenway; G A Bray
Related Documents :
1570777 - Superficial liposuction: a new application of the technique for aged and flaccid skin.
18520837 - Periocular autologous coleman fat graft survival and histopathology.
19568047 - A murine model for studying diffusely injected human fat.
6773327 - Infrapatellar pigmented villonodular synovitis: arthrographic detection.
19356757 - Antiretroviral compounds and cholesterol efflux from macrophages.
2025787 - Gemfibrozil therapy in primary type ii hyperlipoproteinemia: effects on lipids, lipopro...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinical therapeutics     Volume:  9     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:  1987  
Date Detail:
Created Date:  1988-04-11     Completed Date:  1988-04-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  663-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, UCLA School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / metabolism
Administration, Cutaneous
Adrenergic alpha-Antagonists / administration & dosage,  therapeutic use*
Adrenergic beta-Agonists / administration & dosage,  therapeutic use*
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Injections
Lipolysis / drug effects
Obesity / drug therapy*,  metabolism
Phosphodiesterase Inhibitors / administration & dosage,  therapeutic use
Thigh
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Agonists; 0/Phosphodiesterase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance...
Next Document:  Aminergic and peptidergic amplification of intracellular cyclic AMP levels in a molluscan neural net...